Beyond Cholesterol: The Atherogenic Consequences of Combined Dyslipidemia

被引：9
|
作者：
Kavey, Rae-Ellen W. [1 ]
Mietus-Snyder, Michele [2 ,3 ]
机构：
[1] Univ Rochester, Med Ctr, Div Pediat Cardiol, Rochester, NY 14690 USA
[2] George Washington Univ, Dept Pediat, Washington, DC 20052 USA
[3] Childrens Natl Med Ctr, Obes Inst, Med Ctr, Washington, DC 20010 USA
来源：
JOURNAL OF PEDIATRICS | 2012年 / 161卷 / 06期
关键词：
DENSITY LIPOPROTEIN CHOLESTEROL; RISK; ATHEROSCLEROSIS; DISEASE;
D O I：
10.1016/j.jpeds.2012.07.034
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：977 / 979
页数：3
相关论文
共 50 条
  • [21] Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
    Alexander Tenenbaum
    Enrique Z Fisman
    Michael Motro
    Yehuda Adler
    Cardiovascular Diabetology, 5
  • [22] Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
    Basoglu, Ozen K.
    Tasbakan, Mehmet S.
    Kayikcioglu, Meral
    SLEEP MEDICINE, 2021, 88 : 29 - 35
  • [23] Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia
    O'Hagan, Ross
    Berg, Alex R.
    Hong, Christin G.
    Parel, Philip M.
    Mehta, Nehal N.
    Teague, Heather L.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia
    Yu, Y
    Wyszynski, DF
    Waterworth, DM
    Wilton, SD
    Barter, PJ
    Kesäniemi, YA
    Mahley, RW
    McPherson, R
    Waeber, G
    Bersot, TP
    Ma, QL
    Sharma, SS
    Montgomery, DS
    Middleton, LT
    Sundseth, SS
    Mooser, V
    Grundy, SM
    Farrer, LA
    JOURNAL OF LIPID RESEARCH, 2005, 46 (10) : 2202 - 2213
  • [25] Combined therapy with omega-3 fatty acids and niacin in atherogenic dyslipidemia.
    Harris, WS
    Miles, JM
    FASEB JOURNAL, 2001, 15 (04): : A639 - A639
  • [26] Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
    Makadia, Sunal S.
    Blaha, Michael
    Keenan, Tanya
    Ndumele, Chiadi
    Jones, Steven
    DeFilippis, Andrew
    Martin, Seth
    Kohli, Payal
    Conceicao, Raquel
    Carvalho, Jose
    Nasir, Khurram
    Blumenthal, Roger
    Santos, Raul D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (10): : 1599 - 1604
  • [27] APOPROTEIN B: A MARKER OF ATHEROGENIC DYSLIPIDEMIA
    Antonio, N.
    Lourenco, C.
    Monteiro, S.
    Costa, S.
    Monteiro, P.
    Goncalves, F.
    Goncalves, L.
    Freitas, M.
    Providencia, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 89 - 89
  • [28] Atherogenic dyslipidemia: A multidisciplinary consensus panel
    不详
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2013, 25 (02): : 83 - 91
  • [29] Decalogue of clinical recommendations on atherogenic dyslipidemia
    Pedro-Botet, Juan
    Millan, Jesus
    Brea, Angel
    Diaz, Angel
    Gonzalez-Santos, Pedro
    Hernandez-Mijares, Antonio
    Mantilla, Teresa
    Pinto, Xavier
    Simo, Rafael
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2014, 26 (01): : 38 - 40
  • [30] Dietary and genetic probes of atherogenic dyslipidemia
    Krauss, RM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (11) : 2265 - 2272
12345